Toshifumi Hoki retweetledi

🔥Excellent news: Pivotal phase III IMbrave050 study is positive: The first positive adjuvant trial in #HCC🔥
👉Atezolizumab + Avastin improves RFS in pts at high risk of recurrence following surgery
@myESMO @OncoAlert @EASLedu #livertwitter

English


















